New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
15:24 EDTMONMonsanto January volatility up into Q1 and revenue growth outlook
Monsanto January put option implied volatility is at 26, February is at 22, April is at 25, July is at 27; compared to its 26-week average of 24 according to Track Data, suggesting non-directional price movement into its expected release of Q1 results before the market open on January 8.
News For MON From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent MON news | >>
April 1, 2015
09:15 EDTMONMonsanto reports Intacta RR2 PRO penetration at 15M acres
Subscribe for More Information
08:09 EDTMONMonsanto down 1.6% after Q2 ongoing earnings miss expectations
Subscribe for More Information
08:08 EDTMONMonsanto reports Q2 Seeds and Genomics sales $4.18B
Reports Q2 Agricultural Productivity sales $1.02B. Monsanto said Q2 results were aligned with the company’s guidance, with its performance reflecting in part the previously outlined expected shift in gross profit from the U.S. Channel seed brand business of approximately $275M from the second quarter to the third quarter. This was balanced against strong soybean performance in South America and the United States. In Agricultural Productivity, the decline in gross profit was primarily volume related, as the company continued to convert from non-branded to branded volumes of Roundup, which is shifting gross profit to the second half to support key application windows for over-the-top sprays.
08:07 EDTMONMonsanto now sees FY15 Seeds/Genomics gross profit up low-to-mid-single digits
Monsanto said the Seeds and Genomics segment gross profit growth percentage for the full year is now expected to be low-to-mid-single digits, while the company’s Agricultural Productivity gross profit is still expected to be down approximately 10% versus the prior year due to anticipated generic glyphosate price softening and an incremental 2-to-3% due to deteriorating currencies.
08:05 EDTMONMonsanto now sees FY15 ongoing EPS in low end of $5.75-$6.00 range
Subscribe for More Information
08:03 EDTMONMonsanto sees at least doubling ongoing EPS by 2019
“The key milestones we achieved in the first half of fiscal year 2015 are a cornerstone to the long-term growth drivers needed to propel us to our target to more than double ongoing earnings per share by 2019. As we move into the second half of the year, we remain focused on our long-term growth drivers, with disciplined near-term execution and focus on our customers,” said Hugh Grant, chairman and CEO for Monsanto.
08:01 EDTMONMonsanto reports Q2 ongoing EPS $2.90, consensus $2.93
Reports Q2 revenue $5.2B, consensus $5.58B.
March 31, 2015
15:20 EDTMONNotable companies reporting before tomorrow's open
Subscribe for More Information
15:11 EDTMONMonsanto April weekly 113 straddle priced for 2.9% movement into Q2
Subscribe for More Information
March 30, 2015
08:34 EDTMONMonsanto April volatility elevated into Q2 and outlook
Monsanto April weekly call option implied volatility is at 43, April is at 23, July is at 18; compared to its 26-week average of 18 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on April 1.
07:39 EDTMONRecord soy plantings seen weighing on prices, WSJ says
Analysts expect soybean acreage to rise 3% from last year to 85.9M acres and corn to fall 2% to 88.7M acres, according to a survey by The Wall Street Journal taken ahead of a U.S. Department of Agriculture forecast due Tuesday. Many are betting that further soy production increases will trigger steep declines in futures, the report noted. Publicly traded companies in the agriculture and fertilizers space include Agrium (AGU), Andersons (ANDE), Archer Daniels (ADM), Bunge (BG), CF Industries (CF), Compass Minerals (CMP), DuPont (DD), Intrepid Potash (IPI), Monsanto (MON), Mosaic (MOS), Potash (POT) and Syngenta (SYT). Reference Link
07:24 EDTMONSusquehanna to hold a conference
Subscribe for More Information
March 26, 2015
07:25 EDTMONMonsanto volatility elevated into Q2 and outlook
Subscribe for More Information
March 23, 2015
13:39 EDTMONMonsanto addresses assessment on glyphosate by IARC
Monsanto Company further addressed last week’s assessment on glyphosate by the International Agency for Research on Cancer. “We are outraged with this assessment,” said Dr. Robb Fraley, Monsanto’s Chief Technology Officer. “This conclusion is inconsistent with the decades of ongoing comprehensive safety reviews by the leading regulatory authorities around the world that have concluded that all labeled uses of glyphosate are safe for human health. This result was reached by selective ‘cherry picking’ of data and is a clear example of agenda-driven bias.” The repeated safety assessments by regulatory authorities over the last three decades have formed the foundation for the long history of safe, highly effective use of this important agricultural tool in more than 160 countries around the world. Decisions regarding product safety and approvals for pesticides are governed by regulatory agencies such as the U.S. Environmental Protection Agency and the European Commission, as well as independent scientific advisory bodies such as the European Food Safety Authority. IARC has no regulatory authority and its decision does not impact glyphosate’s label, current registration or use. “Safety is the top priority for every person who works at Monsanto. Glyphosate-based herbicides on the market meet the rigorous standards set by the regulatory and health authorities who work every day to protect human health, and we want our customers and consumers to be assured of these evaluations,” Fraley added. In contrast to the comprehensive review that regulators around the world have completed over three decades, IARC issued its classification based on a limited data review after hours of discussion at a one-week meeting. Further, IARC is one of four programs within the WHO that have reviewed the safety of glyphosate and their classification is inconsistent with the assessments of the other programs. Two of the WHO programs – the Core Assessment Group and the International Programme on Chemical Safety – both concluded glyphosate is not carcinogenic. The WHO Guidelines for Drinking-Water Quality program concluded glyphosate does not represent a hazard to human health.
12:17 EDTMONOn The Fly: Midday Wrap
Subscribe for More Information
11:21 EDTMONOrigin Agritech shares spike higher after report of possible takeover interest
Subscribe for More Information
11:07 EDTMONMonsanto weakness on Glyphosate WHO claims overblown, says Piper Jaffray
Subscribe for More Information
09:46 EDTMONScotts Miracle-Gro slips after report on Monsanto herbicide
Subscribe for More Information
March 22, 2015
16:22 EDTMONChina looks to develop seed program to fend off foreign competition, WSJ says
Subscribe for More Information
14:27 EDTMONWHO says herbicide marketed by Monsanto likely carcinogenic, WSJ says
A World Health Organization agency said Friday that Glyphosate, a herbicide marketed by Monsanto under the Roundup brand and other companies, has the potential to cause cancer in humans, says the Wall Street Journal. Monsanto contested the findings saying that glyphosate is safe if used as recommended by its label and that decades of extensive study have proven its safety, added the Wall Street Journal. Reference Link
1 | 2 | all recent MON news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use